{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:10Z","timestamp":1792788490357,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T00:00:00Z","timestamp":1547164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T00:00:00Z","timestamp":1547164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Jiangsu Province\u2019s Key Discipline \/ Laboratory of Medicine","award":["XK201118"],"award-info":[{"award-number":["XK201118"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2017YFA0103700"],"award-info":[{"award-number":["2017YFA0103700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC-81770258"],"award-info":[{"award-number":["NSFC-81770258"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31500944"],"award-info":[{"award-number":["31500944"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018556","name":"Science and Technology Project of Suzhou","doi-asserted-by":"crossref","award":["SYS201705"],"award-info":[{"award-number":["SYS201705"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Clinical Key Specialty of Cardiovascular Surgery, Jiangsu Clinical Research Center for Cardiovascular Surgery","award":["BL201451"],"award-info":[{"award-number":["BL201451"]}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20150687"],"award-info":[{"award-number":["BK20150687"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20160321"],"award-info":[{"award-number":["BK20160321"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taishan Scholar Project of Shandong Province of China","award":["tsqn20161066"],"award-info":[{"award-number":["tsqn20161066"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cell therapy remains the most promising approach against ischemic heart injury. However, poor survival of engrafted cells in ischemic sites diminishes its therapeutic efficacy. Follistatin-like 1 (Fstl1) is documented as a novel pro-survival cardiokine for cardiomyocytes, and it is protective during ischemic heart injury. In the present study, we characterize the potential of Fstl1 as an effective strategy to enhance hypoxia resistance of donor cells and optimize stem cell-based therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Murine bone marrow-derived mesenchymal stem cells (MSCs) were expanded in monolayer culture and characterized by flow cytometry. MSCs were subjected to hypoxia to mimic cardiac ischemic environment. Expression of Fstl1 was monitored 0, 24, and 48\u2009h following hypoxia. Constitutive expression of Fstl1 in MSCs was achieved by lentivirus-mediated Fstl1 overexpression. Genetically modified MSCs were further collected for cell death and proliferation assay following 48\u2009h of hypoxic treatment. Acute myocardial infarction (MI) model was created by ligating the left anterior descending coronary artery, while control MSCs (MSCs-mCherry) or Fstl1-overexpressing MSCs (MSCs-Fstl1) were injected into the peri-infarct zone simultaneously. Subsequently, retention of the donor cells was evaluated on post-therapy 1, 3, &amp; 7\u2009days. Finally, myocardial function, infarct size, inflammation, and neovascularization of the infarcted hearts were calculated thereafter.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Expression of Fstl1 in hypoxic MSCs declines dramatically in a time-dependent manner. In vitro study further demonstrated that Fstl1 promotes survival and proliferation of hypoxic MSCs. Moreover, Fstl1 significantly prolongs MSC survival\/retention after implantation. Finally, transplantation with Fstl1-overexpressing MSCs significantly improves post-MI cardiac function by limiting scar formation, reducing inflammatory response, and enhancing neovascularization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results suggest Fstl1 is an intrinsic cardiokine promoting survival and proliferation of MSCs, thereby optimizing their engraftment and therapeutic efficacy during cell therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-018-1111-y","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T06:49:56Z","timestamp":1547189396000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model"],"prefix":"10.1186","volume":"10","author":[{"given":"Han","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxue","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiansheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9232-9027","authenticated-orcid":false,"given":"Weiqian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenya","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,11]]},"reference":[{"key":"1111_CR1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.stem.2013.05.008","volume":"12","author":"JC Garbern","year":"2013","unstructured":"Garbern JC, Lee RT. Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell. 2013;12:689\u201398.","journal-title":"Cell Stem Cell"},{"key":"1111_CR2","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1161\/CIRCRESAHA.111.243147","volume":"109","author":"AR Williams","year":"2011","unstructured":"Williams AR, Hare JM. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res. 2011;109:923\u201340.","journal-title":"Circ Res"},{"key":"1111_CR3","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.jacc.2013.02.071","volume":"61","author":"J Bartunek","year":"2013","unstructured":"Bartunek J, Behfar A, Dolatabadi D, et al. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J Am Coll Cardiol. 2013;61:2329\u201338.","journal-title":"J Am Coll Cardiol"},{"key":"1111_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1432-1033.1993.tb18212.x","volume":"217","author":"M Shibanuma","year":"1993","unstructured":"Shibanuma M, Ji M, Mita A, et al. Cloning from a mouse osteoblastic cell line of a set of transforming-growth-factor-\u03b21-regulated genes, one of which seems to encode a follistatin-related polypeptide. Eur J Biochem. 1993;217:13\u20139.","journal-title":"Eur J Biochem"},{"key":"1111_CR5","doi-asserted-by":"publisher","first-page":"32802","DOI":"10.1074\/jbc.M803440200","volume":"283","author":"N Ouchi","year":"2008","unstructured":"Ouchi N, Oshima Y, Ohashi K, et al. Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism. J Biol Chem. 2008;283:32802\u201311.","journal-title":"J Biol Chem"},{"key":"1111_CR6","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1161\/CIRCULATIONAHA.108.767673","volume":"117","author":"Y Oshima","year":"2008","unstructured":"Oshima Y, Ouchi N, Sato K, et al. Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart. Circulation. 2008;117:3099\u2013108.","journal-title":"Circulation"},{"key":"1111_CR7","doi-asserted-by":"publisher","first-page":"E899","DOI":"10.1073\/pnas.1108559108","volume":"108","author":"M Shimano","year":"2011","unstructured":"Shimano M, Ouchi N, Nakamura K, et al. Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload. Proc Natl Acad Sci U S A. 2011;108:E899\u2013906.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1111_CR8","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.bbrc.2015.12.026","volume":"469","author":"W Chen","year":"2016","unstructured":"Chen W, Xia J, Hu P, et al. Follistatin-like 1 protects cardiomyoblasts from injury induced by sodium nitroprusside through modulating Akt and Smad1\/5\/9 signaling. Biochem Biophys Res Commun. 2016;469:418\u201323.","journal-title":"Biochem Biophys Res Commun"},{"key":"1111_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.diff.2013.07.002","volume":"86","author":"J He","year":"2013","unstructured":"He J, Teng X, Yu Y, et al. Injection of Sca-1+\/CD45+\/CD31+ mouse bone mesenchymal stromal-like cells improves cardiac function in a mouse myocardial infarct model. Differentiation. 2013;86:57\u201364.","journal-title":"Differentiation"},{"key":"1111_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11010-015-2624-7","volume":"412","author":"W Chen","year":"2016","unstructured":"Chen W, Wang S, Xia J, et al. Protein phosphatase 2A plays an important role in migration of bone marrow stroma cells. Mol Cell Biochem. 2016;412:173\u201380.","journal-title":"Mol Cell Biochem"},{"key":"1111_CR11","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1016\/j.ajpath.2011.01.041","volume":"178","author":"W Chen","year":"2011","unstructured":"Chen W, Gu P, Jiang X, et al. Protein phosphatase 2A catalytic subunit \u03b1 (PP2Ac\u03b1) maintains survival of committed erythroid cells in fetal liver erythropoiesis through the STAT5 pathway. Am J Pathol. 2011;178:2333\u201343.","journal-title":"Am J Pathol"},{"key":"1111_CR12","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.bbrc.2015.09.044","volume":"466","author":"J Wu","year":"2015","unstructured":"Wu J, Dong Y, Teng X, et al. Follistatin-like 1 attenuates differentiation and survival of erythroid cells through Smad2\/3 signaling. Biochem Biophys Res Commun. 2015;466:711\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"1111_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13287-018-0861-x","volume":"9","author":"J Hou","year":"2018","unstructured":"Hou J, Wang L, Wu Q, et al. Long noncoding RNA H19 upregulates vascular endothelial growth factor A to enhance mesenchymal stem cells survival and angiogenic capacity by inhibiting miR-199a-5p. Stem Cell Res Ther. 2018;9:109.","journal-title":"Stem Cell Res Ther"},{"key":"1111_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.yexmp.2017.01.015","volume":"102","author":"J Hou","year":"2017","unstructured":"Hou J, Zhong T, Guo T, et al. Apelin promotes mesenchymal stem cells survival and vascularization under hypoxic-ischemic condition in vitro involving the upregulation of vascular endothelial growth factor. Exp Mol Pathol. 2017;102:203\u20139.","journal-title":"Exp Mol Pathol"},{"key":"1111_CR15","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1159\/000438594","volume":"37","author":"X Teng","year":"2015","unstructured":"Teng X, Chen L, Chen W, et al. Mesenchymal stem cell-derived exosomes improve the microenvironment of infarcted myocardium contributing to angiogenesis and anti-inflammation. Cell Physiol Biochem. 2015;37:2415\u201324.","journal-title":"Cell Physiol Biochem"},{"key":"1111_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s13287-017-0722-z","volume":"8","author":"Y Chen","year":"2017","unstructured":"Chen Y, Zhao Y, Chen W, et al. MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction. Stem Cell Res Ther. 2017;8:268.","journal-title":"Stem Cell Res Ther"},{"key":"1111_CR17","doi-asserted-by":"crossref","unstructured":"Chen W, Huang Z, Jiang X, et al. Overexpression of myeloid differentiation protein 88 in mice induces mild cardiac dysfunction, but no deficit in heart morphology. Braz J Med Biol Res. 2016;49:e4794.","DOI":"10.1590\/1414-431x20154794"},{"key":"1111_CR18","doi-asserted-by":"publisher","unstructured":"Xiao Y, Zhang Y, Chen Y, et al. Inhibition of microRNA-9-5p protects against cardiac remodeling following myocardial infarction in mice. Hum Gene Ther. 2018. https:\/\/doi.org\/10.1089\/hum.2018.059.","DOI":"10.1089\/hum.2018.059"},{"key":"1111_CR19","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.ajpath.2011.10.034","volume":"180","author":"Y Zhou","year":"2012","unstructured":"Zhou Y, Jiang X, Gu P, et al. Gsdma3 mutation causes bulge stem cell depletion and alopecia mediated by skin inflammation. Am J Pathol. 2012;180:763\u201374.","journal-title":"Am J Pathol"},{"key":"1111_CR20","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.bbrc.2016.08.090","volume":"478","author":"J Wu","year":"2016","unstructured":"Wu J, Wang J, Zeng X, et al. Protein phosphatase 2A regulatory subunit B56\u03b2 modulates erythroid differentiation. Biochem Biophys Res Commun. 2016;478:1179\u201384.","journal-title":"Biochem Biophys Res Commun"},{"key":"1111_CR21","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1038\/ncomms5282","volume":"5","author":"Z Huang","year":"2014","unstructured":"Huang Z, Ruan H-B, Xian L, et al. The stem cell factor\/Kit signalling pathway regulates mitochondrial function and energy expenditure. Nat Commun. 2014;5:4282.","journal-title":"Nat Commun"},{"key":"1111_CR22","doi-asserted-by":"publisher","first-page":"5406","DOI":"10.1111\/jcmm.13812","volume":"22","author":"J Li","year":"2018","unstructured":"Li J, Liu S, Cao G, et al. Nicotine induces endothelial dysfunction and promotes atherosclerosis via GTPCH1. J Cell Mol Med. 2018;22:5406\u201317.","journal-title":"J Cell Mol Med"},{"key":"1111_CR23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315\u20137.","journal-title":"Cytotherapy"},{"key":"1111_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s13287-017-0697-9","volume":"8","author":"C Miao","year":"2017","unstructured":"Miao C, Lei M, Hu W, et al. A brief review: the therapeutic potential of bone marrow mesenchymal stem cells in myocardial infarction. Stem Cell Res Ther. 2017;8:242.","journal-title":"Stem Cell Res Ther"},{"key":"1111_CR25","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00441-016-2431-9","volume":"365","author":"V Talman","year":"2016","unstructured":"Talman V, Ruskoaho H. Cardiac fibrosis in myocardial infarction\u2014from repair and remodeling to regeneration. Cell Tissue Res. 2016;365:563\u201381.","journal-title":"Cell Tissue Res"},{"key":"1111_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res. 2016;119:91\u2013112.","journal-title":"Circ Res"},{"key":"1111_CR27","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1084\/jem.20070885","volume":"204","author":"M Nahrendorf","year":"2007","unstructured":"Nahrendorf M, Swirski FK, Aikawa E, et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med. 2007;204:3037\u201347.","journal-title":"J Exp Med"},{"key":"1111_CR28","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1161\/01.CIR.101.25.2981","volume":"101","author":"MG Sutton","year":"2000","unstructured":"Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. 2000;101:2981\u20138.","journal-title":"Circulation"},{"key":"1111_CR29","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1161\/CIRCULATIONAHA.109.916346","volume":"121","author":"M Nahrendorf","year":"2010","unstructured":"Nahrendorf M, Pittet MJ, Swirski FK. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation. 2010;121:2437\u201345.","journal-title":"Circulation"},{"key":"1111_CR30","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1161\/CIRCRESAHA.113.301720","volume":"114","author":"MA Ismahil","year":"2014","unstructured":"Ismahil MA, Hamid T, Bansal SS, et al. Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis. Circ Res. 2014;114:266\u201382.","journal-title":"Circ Res"},{"key":"1111_CR31","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s13287-017-0695-y","volume":"8","author":"S Roura","year":"2017","unstructured":"Roura S, Galvez-Monton C, Mirabel C, et al. Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario? Stem Cell Res Ther. 2017;8:238.","journal-title":"Stem Cell Res Ther"},{"key":"1111_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/2045893217702340","volume":"7","author":"NP Tania","year":"2017","unstructured":"Tania NP, Maarsingh H, IS TB, et al. Endothelial follistatin-like-1 regulates the postnatal development of the pulmonary vasculature by modulating BMP\/Smad signaling. Pulm Circ. 2017;7:219\u201331.","journal-title":"Pulm Circ"},{"key":"1111_CR33","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/CIRCRESAHA.115.305227","volume":"118","author":"KM Broughton","year":"2016","unstructured":"Broughton KM, Sussman MA. Empowering adult stem cells for myocardial regeneration V2.0 success in small steps. Circ Res. 2016;118:867\u201380.","journal-title":"Circ Res"},{"key":"1111_CR34","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/j.1582-4934.2010.01255.x","volume":"15","author":"Z Wen","year":"2011","unstructured":"Wen Z, Zheng S, Zhou C, et al. Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction. J Cell Mol Med. 2011;15:1032\u201343.","journal-title":"J Cell Mol Med"},{"key":"1111_CR35","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1582-4934.2011.01471.x","volume":"16","author":"Z Wen","year":"2012","unstructured":"Wen Z, Zheng S, Zhou C, et al. Bone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: microRNAs as novel regulators. J Cell Mol Med. 2012;16:657\u201371.","journal-title":"J Cell Mol Med"},{"key":"1111_CR36","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1161\/CIRCRESAHA.115.307362","volume":"117","author":"S Mohsin","year":"2015","unstructured":"Mohsin S, Troupes CD, Starosta T, et al. Unique features of cortical bone stem cells associated with repair of the injured heart. Circ Res. 2015;117:1024\u201333.","journal-title":"Circ Res"},{"key":"1111_CR37","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1084\/jem.20150806","volume":"213","author":"P Holmfeldt","year":"2016","unstructured":"Holmfeldt P, Ganuza M, Marathe H, et al. Functional screen identifies regulators of murine hematopoietic stem cell repopulation. J Exp Med. 2016;213:433\u201349.","journal-title":"J Exp Med"},{"key":"1111_CR38","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1038\/s41467-018-05038-2","volume":"9","author":"R Guo","year":"2018","unstructured":"Guo R, Ye X, Yang J, et al. Feeders facilitate telomere maintenance and chromosomal stability of embryonic stem cells. Nat Commun. 2018;9:2620.","journal-title":"Nat Commun"},{"key":"1111_CR39","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/nm912","volume":"9","author":"AA Mangi","year":"2003","unstructured":"Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med. 2003;9:1195\u2013201.","journal-title":"Nat Med"},{"key":"1111_CR40","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature15372","volume":"525","author":"K Wei","year":"2015","unstructured":"Wei K, Serpooshan V, Hurtado C, et al. Epicardial FSTL1 reconstitution regenerates the adult mammalian heart. Nature. 2015;525:479\u201385.","journal-title":"Nature"},{"key":"1111_CR41","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.yexmp.2005.07.005","volume":"80","author":"S Liu","year":"2006","unstructured":"Liu S, Wang L, Wang W, et al. TSC-36\/FRP inhibits vascular smooth muscle cell proliferation and migration. Exp Mol Pathol. 2006;80:132\u201340.","journal-title":"Exp Mol Pathol"},{"key":"1111_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/cvr\/cvu105","volume":"103","author":"M Miyabe","year":"2014","unstructured":"Miyabe M, Ohashi K, Shibata R, et al. Muscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injury. Cardiovasc Res. 2014;103:111\u201320.","journal-title":"Cardiovasc Res"},{"key":"1111_CR43","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/carcin\/bgn215","volume":"30","author":"QK Chan","year":"2009","unstructured":"Chan QK, Ngan HY, Ip PP, et al. Tumor suppressor effect of follistatin-like 1 in ovarian and endometrial carcinogenesis: a differential expression and functional analysis. Carcinogenesis. 2009;30:114\u201321.","journal-title":"Carcinogenesis"}],"updated-by":[{"DOI":"10.1186\/s13287-024-03662-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000}}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-018-1111-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-018-1111-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-018-1111-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T06:08:39Z","timestamp":1708409319000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-018-1111-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,11]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["1111"],"URL":"https:\/\/doi.org\/10.1186\/s13287-018-1111-y","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,11]]},"assertion":[{"value":"13 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13287-024-03662-y","URL":"https:\/\/doi.org\/10.1186\/s13287-024-03662-y","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the Ethics Committee of Soochow University (Ref: SZUM2008031233) and were conducted according to institutional animal ethics guidelines for the Care and Use of Research Animals established by Soochow University, Suzhou, China.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"17"}}